Role of gut microbiota in melanosis coli: from anthraquinone biotransformation to mucosal homeostasis dysbiosis
Frontiers in Pharmacology · 17.06.2026 · 17
DOI: 10.3389/fphar.2026.1791164 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 17.06.2026. Verfasst von Peng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Qujing Hospital of Traditional Chinese Medicine, Qujing, Yunnan, China. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Melanosis coli (MC) is a benign and usually reversible condition characterized by brownish-black pigmentation of the colonic mucosa and is commonly associated with chronic exposure to anthraquinone laxatives (ALs). The best-established histopathological sequence involves AL-related epithelial apoptosis, phagocytosis of apoptotic bodies by macrophages, and subsequent lipofuscin deposition. Emerging evidence suggests that the gut microbiota (GM) may contribute to this process by converting pharmacologically inactive anthraquinone glycosides into active anthrone metabolites, including rhein anthrone. This narrative review summarizes available MC-specific findings and clearly distinguishes them from mechanistic hypotheses extrapolated from constipation, intestinal barrier, and microbiome literature. We discuss microbial β-glucosidases and reductases involved in AL biotransformation, reported changes in microbial diversity and SCFA-producing taxa in MC or constipation-associated cohorts, and plausible links with barrier dysfunction, bile-acid metabolism, tryptophan-derived metabolites, and LPS-TLR4 signaling. We therefore present the “Microbiota-Apoptosis Axis” as a proposed framework rather than a validated causal pathway. Finally, we review GM-targeted strategies, including probiotics, synbiotics, and fecal microbiota transplantation, while emphasizing that direct clinical evidence in MC remains limited and that cessation of anthraquinone laxatives remains the primary management strategy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Qujing Hospital of Traditional Chinese Medicine, Qujing, Yunnan, China.
- Mengzi Hospital of Traditional Chinese Medicine, Mengzi, Yunnan, China.
Zitieren
APA
Zhang, P., Zhuang, Y. D., Lv, W. W., Zhao, Y., Wang, J. H., Zhang, J. Y., & Wu, L. L. (2026). Role of gut microbiota in melanosis coli: from anthraquinone biotransformation to mucosal homeostasis dysbiosis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1791164
Vancouver
Zhang P, Zhuang YD, Lv WW, Zhao Y, Wang JH, Zhang JY, et al. Role of gut microbiota in melanosis coli: from anthraquinone biotransformation to mucosal homeostasis dysbiosis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1791164
BibTeX
@article{Zhang2026,
author = {Zhang, Peng and Zhuang, Yuan-Dan and Lv, Wen-Wen and Zhao, Yuan and Wang, Ji-Hou and Zhang, Jv-Ying and Wu, Li-Long},
title = {Role of gut microbiota in melanosis coli: from anthraquinone biotransformation to mucosal homeostasis dysbiosis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1791164}
}
EUVIMED